Publications

arsenic (9 POSTS)

2021 (1 POST)

Selective pressure responsible for pathway evolution of arsenic tolerance in bioenergy algae

Jacobellis M, Blaby-Haas C. Selective pressure responsible for pathway evolution of arsenic tolerance in bioenergy algae. Science Undergraduate Laboratory Internship (SULI) Presentations, Brookhaven National Laboratory, Upton, NY, 2021.

2017 (1 POST)

Benchmark dose modeling estimates of the concentrations of inorganic arsenic that induce changes to the neonatal transcriptome, proteome, and epigenome in a pregnancy cohort

Rager JE, Auerbach SS, Chappell GA, Martin E, Thompson C, Fry RC. 2017. Benchmark dose modeling estimates of the concentrations of inorganic arsenic that induce changes to the neonatal transcriptome, proteome, and epigenome in a pregnancy cohort. Chem Res Toxicol 30(10):1911-1920; doi: 10.1021/acs.chemrestox.7b00221.

View Abstract

2016 (2 POSTS)

Integrating genomic and epigenomic data into risk assessment applications through dose response modeling: Case study with prenatal arsenic exposure

Rager J, Thompson C, Auerbach S, Fry R. Integrating genomic and epigenomic data into risk assessment applications through dose response modeling: Case study with prenatal arsenic exposure. Environmental Mutagenesis and Genomics Society, Kansas City, KS, September 2016.

View Abstract

Analysis of total arsenic content in California wines and comparison to various health risk criteria

Paustenbach DJ, Insley AL, Maskrey JR, Bare JL, Unice KM, Conrad VB, Iordanidis L, Reynolds DW, DiNatale KD, Monnot AD. 2016. Analysis of total arsenic content in California wines and comparison to various health risk criteria. Am J Enol Viticult 67(2):179–187; doi: 10.5344/ajev.2015.15041.

2012 (1 POST)

Predicting later-life outcomes of early-life exposures

Boekelheide K, Blumberg B, Chapin RE, Cote I, Graziano JH, Janesick A, Lane R, Lilycrop K, Myatt L, States JC, Thayer KA, Waalkes MP, Rogers JM. 2012. Predicting later-life outcomes of early-life exposures. Environ Health Perspect 120:1353–1361; doi: 10.1289/ehp.1204934.

View Abstract

2008 (2 POSTS)

Low-level arsenic exposure in drinking water and bladder cancer: A review and meta-analysis

Mink PJ, Alexander DD, Barraj LM, Kelsh MA, Tsuji JS. 2008. Low-level arsenic exposure in drinking water and bladder cancer: A review and meta-analysis. Regul Toxicol Pharmacol 52(3):299–310.

View Abstract

Risk assessment for arsenic on indoor surfaces

Williams CW, Perry CS. Risk assessment for arsenic on indoor surfaces. Presented at the Society for Risk Analysis Annual Meeting, Boston, MA, December 2008.

1997 (2 POSTS)

Cytogenetic effects in human exposure to arsenic

Gonesbatt ME, Vega L, Salazar AM, Montero R, Guzman P, Blas J, … Kelsh MA, et al. 1997. Cytogenetic effects in human exposure to arsenic. Mutat Res 386(3):219–228; doi: 10.1016/s1383-5742(97)00009-4. PMID: 9219560.

View Abstract

Altered profile of urinary arsenic metabolites in adults with chronic arsenicism

Del Razo LM, Garcia–Vargas GG, Vargas H, Albores A, Gonesbatt ME, Montero R, Ostrosky–Wegman P, Kelsh MA, et al. 1997. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. Arch Toxicol 71(4):211–217; doi: 10.1007/s002040050378. PMID: 9101036.

View Abstract